David Knipe, PhD
Higgins Professor of Microbiology and Molecular Genetics, Harvard Medical School
Mechanisms of Host IFI16, PML, and Daxx Protein Restriction of Herpes Simplex Virus 1 Replication.
Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cells.
Authors: Authors: Thomann S, Boscheinen JB, Vogel K, Knipe DM, DeLuca N, Gross S, Schuler-Thurner B, Schuster P, Schmidt B.
Immunology
View full abstract on Pubmed
Immunology
View full abstract on Pubmed
Cellular sensing of viral DNA and viral evasion mechanisms.
Role of specific innate immune responses in herpes simplex virus infection of the central nervous system.
Authors: Authors: Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA.
J Virol
View full abstract on Pubmed
J Virol
View full abstract on Pubmed
Genetic engineering of a modified herpes simplex virus 1 vaccine vector.
Authors: Authors: Liu X, Broberg E, Watanabe D, Dudek T, Deluca N, Knipe DM.
Vaccine
View full abstract on Pubmed
Vaccine
View full abstract on Pubmed
ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions.
Authors: Authors: Orlando JS, Balliet JW, Kushnir AS, Astor TL, Kosz-Vnenchak M, Rice SA, Knipe DM, Schaffer PA.
J Virol
View full abstract on Pubmed
J Virol
View full abstract on Pubmed
Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors.
Authors: Authors: Fontaine-Rodriguez EC, Taylor TJ, Olesky M, Knipe DM.
Virology
View full abstract on Pubmed
Virology
View full abstract on Pubmed
Viral vaccines: Past, present and future
Authors: Authors: Knipe DM
Medicina Universitaria
Medicina Universitaria
Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.
Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.